Skip to main content
logo
Option Therapeutics Inc. (OPTN)
Option Therapeutics will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$10.00 - $12.00
Shares Offered
1,818,182
Deal Size
$20.00M

Option Therapeutics Financials Overview

Millions USD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingMar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
81.8678.2370.9976.2874.6549.12
Revenue Growth
10.59%10.20%-6.93%2.17%51.99%41.83%
Gross Profit
74.117162.3567.0165.541.6
Operating Income
-15.83-16.32-22.75-55.9-66.45-87.22
Net Income
-29.89-21.54-35.48-74.83-82.3-99.79
Earnings Per Share
-2.67-2.12-4.75-13.07-21.71-31.01
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingMar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Investments
72.9384.4973.6894.24110.5144.16
Total Debt
127.21128.96131.75131.17130.7131.47
Net Cash (Debt)
-54.27-44.48-58.07-36.93-20.212.69
Net Cash Growth
------82.15%
Net Cash Per Share
-4.85-4.38-7.77-6.45-5.333.94

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingMar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Cash Flow
-34.21-44.68-20.53-67.65-76.94-86.21
Capital Expenditures
-0.05-0.07-0.33-0.06-0.17-0.55
Free Cash Flow
-34.26-44.75-20.86-67.71-77.1-86.75
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingMar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Gross Margin
90.53%90.76%87.84%87.86%87.74%84.69%
Operating Margin
-19.34%-20.86%-32.05%-73.28%-89.01%-177.57%
Pretax Margin
-36.52%-27.54%-49.99%-98.11%-110.24%-203.16%
Profit Margin
-36.52%-27.54%-49.98%-98.11%-110.24%-203.16%
FCF Margin
-41.85%-57.21%-29.39%-88.78%-103.28%-176.62%

Valuation
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingAug '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
-0.862.042.661.784.39